Immunotherapy may help in glioblastoma survival

09:53 EDT 16 Mar 2019 | Leaders in Pharmaceutical Business Intelligence

Reporter and Curator: Dr. Sudipta Saha, Ph.D.   Glioblastoma is the most common primary malignant brain tumor in adults and is associated with poor survival. But, in a glimmer of hope, a recent study found that a drug designed to unleash the immune system helped some patients live longer. Glioblastoma powerfully suppresses the immune system, […]

Original Article: Immunotherapy may help in glioblastoma survival

More From BioPortfolio on "Immunotherapy may help in glioblastoma survival"